Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Regen Chemical is a Chinese manufacturer of pharmaceutical raw materials, intermediates, and specialty chemicals based in Taizhou, Zhejiang. The company supplies commercial small-molecule active pharmaceutical ingredients and intermediates across multiple product families, including compounds related to apixaban, rivaroxaban, linagliptin, fluoxetine, lercanidipine, posaconazole, ruxolitinib, finerenone, bictegravir, acalabrutinib, and pirtobrutinib. It also produces specialty chemicals such as piroctone olamine and pyrithione derivatives including zinc pyrithione and copper pyrithione. The company describes itself as a national high-tech enterprise with an in-house provincial R&D center, analytical capabilities, ISO9001 quality certification, and chemical production plus waste-treatment infrastructure. Overall, it appears to be a commercial-stage API and specialty chemical supplier rather than a drug developer with a disclosed proprietary clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Regen Chemical.